That’s why I also recommend cranberry extract. Women have long known how effective this fruit is at preventing urinary tract infections, but a growing amount of research is showing it also reduces urinary tract inflammation and bacteria buildup in both women and men.6 I generally recommend at least 1,000 mg of cranberry extract per day in supplement form, as the juice is loaded with too much sugar.

Tea and stinging nettle also help promote urinary tract health. In one study of 46 men, a green tea-black tea extract increased urine flow and reduced the amount of urine left in the bladder after urination in as little as six weeks.7 Patients took either 500 mg or 1,000 mg per day. Both dosages showed a positive effect.

And a review of stinging nettle research found that the plant is effective in reducing BPH symptoms, perhaps by affecting hormones (like 5-alpha-reductase inhibitor drugs but without the nasty side effects) and reducing inflammation.8 You will often find this ingredient in combination products for prostate health, typically at lower dosages since it’s being combined with other supportive nutrients and provides a synergistic effect. If you supplement with it individually, studies support the use of up to 300 mg twice a day.

Finally, I’m a big fan of extract of Pygeum Africanum, otherwise known as the African plum tree. A large review of studies shows that this botanical can do it all when it comes to BPH symptoms–increase urine flow by 23 percent, reduce leftover urine in the bladder by 24 percent, and lower the incidences of middle-of-the-night urination by 19 percent.9 Again, you will often find this extract included in a combination prostate support supplement, so it’s easy to find. A safe general dose as a stand-alone supplement is 100 mg to 200 mg per day.

Hopefully now that mainstream doctors know there’s no proof that expensive BPH treatments are any better than the cheaper ones, they’ll finally turn their attention to natural prostate support supplements. They’re proven, safe, and low cost. And we certainly know that’s key in today’s penny-pinching healthcare world.

1Kaplan AL, et al. Measuring the cost of care in benign prostatic hyperplasia using time-driven activity-based costing (TDABC). Healthcare, 2015; 3 (1): 43.

2Parsons JK, et al. Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions.J Urol. 2009 Dec;182(6 Suppl):S27-31.

3Barkin J, et al. Effect of dutasteride, tamsulosin and the combination on patient-reported quality of life and treatment satisfaction in men with moderate-to-severe benign prostatic hyperplasia: 2-year data from the CombAT trial. BJU Int. 2009 Apr;103(7):919-26.

4Fitzpatrick JM. Minimally invasive and endoscopic management of benign prostatic hyperplasia. Campbell-Walsh Urology, 10th ed., vol. 3 (2012). pp. 2655-2694.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s